Alzheimer’s proteins in eyes may be key to early detection

Efforts to detect Alzheimer’s disease earlier and more cheaply are focusing on signs of the ailment in the eye and sense of smell.

Scientists have found that certain biological changes in the retina and lens of the eye, and in the sense of smell, may help predict whether people with no or minor memory issues may go on to develop the progressive brain disease, according to findings presented here Sunday at the Alzheimer’s Association International Conference.

Alzheimer’s disease is diagnosed primarily by clinical examination using memory tests and questions about how a patient is functioning. But researchers are attempting to devise tools, particularly using biological markers, to improve the detection of early stages of the disease, said David Knopman, a neurologist at Mayo Clinic and a member of the Alzheimer’s Association Medical and Scientific Advisory Council.

The disease’s pathology in the brain typically begins decades before the appearance of memory symptoms.

Looking for changes in the eye or smell represent “simpler, less invasive” methods that are more feasible for use in doctor’s offices and other clinical settings, Knopman said.

Read the full, original story: Key to detecting Alzheimer’s early could be in the eye

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Screenshot-2026-05-12-at-10.05.11-AM
Pro-vaccine “hero” vs. an anti-vax “villain”: ‘Bad Vaxx’ video stirs MAHA backlash
ChatGPT Image May 12, 2026, 10_19_00 AM 2
Viewpoint— 'Muscular governance': How authoritarianism is surging corporate-linked energy misinformation
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.